Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| BALOISE | 4 | 13 | +3,03 % | ||
| SGS | 4 | 6 | +1,71 % | ||
| HELVETIA | 3 | 3 | -2,08 % | ||
| FLUGHAFEN ZUERICH | 3 | 2 | +0,09 % | ||
| BELIMO | 3 | - | -100,00 % | ||
| CLARIANT | 2 | 14 | +0,91 % | ||
| TEMENOS | 2 | 1 | +1,10 % | ||
| LINDT & SPRUENGLI | 1 | 3 | +0,12 % | ||
| JULIUS BAER | 1 | 2 | +0,42 % | ||
| SWATCH | 1 | 2 | +0,23 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Julius Baer, SumiTrust Optimistic On Japanese Equities Despite Tariff Turmoil | 2 | WealthBriefing | ||
| Do | Galderma Q1 2025 slides: 8.3% sales growth driven by neuromodulators, guidance confirmed | 3 | Investing.com | ||
| Do | Zealand Pharma gains as trial for Roche-partnered obesity drug starts | 12 | Seeking Alpha | ||
| Do | Roche Stock: Pharma Growth Offsets Diagnostic Challenges | Börse Global (english) | |||
| Do | Nestlé, Lindt und Swatch: Dollar-Talfahrt belastet Gewinnprognosen Internationaler Konzerne | 11 | cash | ||
| Do | Roche's Q1 Sales Increase Y/Y on Solid Performance of Key Drugs | 5 | Zacks | ||
| Do | Roche moves to mitigate US tariff impact amid discussions with global governments | 6 | FiercePharma | ||
| Do | Flughafen Zürich testet Solarzäune - und kündigt PV-Offensive an | 4 | watson | ||
| Do | Roche Q1 2025 presentation slides: Pharma growth offsets flat diagnostics amid China reforms | 5 | Investing.com | ||
| Do | Pharma Giant Roche Tops First-Quarter Views; Sanofi's Sales Come In Mixed | 4 | Investor's Business Daily | ||
| Do | EU pharma majors Sanofi, Roche trade flat after reiterated guidance | 3 | Seeking Alpha | ||
| Do | Standard Chartered integrates FX services with Temenos Exchange | 2 | FinTech Futures | ||
| Do | Roche plant milliardenschwere Expansion trotz drohender Pharmazölle | 7 | IT BOLTWISE | ||
| Do | Roche seeking talks with the US on tariff exemptions | 5 | pharmaphorum | ||
| Do | Roche's Genentech enters $765m autoimmune disease partnership with Repertoire | 7 | PMLiVE | ||
| Do | Tariffs will make financial case for pharma M&A 'more difficult,' says Roche CEO | 11 | FierceBiotech | ||
| Do | Flughafen Zürich testet Solarzäune | 4 | airliners.de | ||
| Do | ROUNDUP: Pharmakonzern Roche legt zum Jahresstart zu - Gut gerüstet für US-Markt | 102 | dpa-AFX | BASEL (dpa-AFX) - Der Schweizer Arzneimittelhersteller Roche hat zum Jahresstart von einer anziehenden Nachfrage nach innovativen Medikamenten profitiert und seinen Umsatz gesteigert. An seinen Zielen... ► Artikel lesen | |
| Do | Helvetia-Baloise merger likely to strengthen the enlarged group's competitive position: S&P | 5 | Reinsurance News | ||
| Do | Repertoire and Genentech to develop autoimmune disease therapies | 3 | Pharmaceutical Technology |
Seite:
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
